Sign in
4

Changes in Ownership

CYTOKINETICS INC Filed Acc 0001127602-25-013404

EVP, Chief Commercial Officer sold 4,002 shares at $36.68 ($146,793)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Callos Andrew · EVP, Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-05 Sale : show line 1 in the form 10b5-1 −4,002 $36.68 $146,793 60,687 D
Open-market sales · 4,002 sh · avg $36.68 · $146,793
Loading xslF345X05/form4.xml…